Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability BH Smith, H Campbell, D Blackwood, J Connell, M Connor, IJ Deary, ... BMC medical genetics 7, 1-9, 2006 | 272 | 2006 |
Tackling Community Concerns about Commercialisation and Genetic Research: A Modest Interdisciplinary Proposal G Haddow, G Laurie, K Hunter, S Cunningham-Burley Elsevier, 2007 | 165 | 2007 |
3D bioprint me: a socioethical view of bioprinting human organs and tissues N Vermeulen, G Haddow, T Seymour, A Faulkner-Jones, W Shu Journal of Medical Ethics 43 (9), 618-624, 2017 | 145 | 2017 |
The phenomenology of death, embodiment and organ transplantation G Haddow Sociology of health & illness 27 (1), 92-113, 2005 | 142 | 2005 |
Promoting research participation: why not advertise altruism? B Williams, V Entwistle, G Haddow, M Wells Social Science & Medicine 66 (7), 1451-1456, 2008 | 129 | 2008 |
Donor and nondonor families' accounts of communication and relations with healthcare professionals G Haddow Progress in Transplantation 14 (1), 41-48, 2004 | 82 | 2004 |
Generation Scotland: consulting publics and specialists at an early stage in a genetic database's development G Haddow, S Cunningham-Burley, A Bruce, S Parry Critical Public Health 18 (2), 139-149, 2008 | 67 | 2008 |
‘Nothing is really safe’: a focus group study on the processes of anonymizing and sharing of health data for research purposes G Haddow, A Bruce, S Sathanandam, JC Wyatt Journal of evaluation in clinical practice 17 (6), 1140-1146, 2011 | 60 | 2011 |
“Because you’re worth it?” The taking and selling of transplantable organs G Haddow Journal of medical ethics 32 (6), 324-328, 2006 | 55 | 2006 |
Cyborgs in the everyday: Masculinity and biosensing prostate cancer G Haddow, E King, I Kunkler, D McLaren Science as Culture 24 (4), 484-506, 2015 | 53 | 2015 |
Not “human” enough to be human but not “animal” enough to be animal–the case of the HFEA, cybrids and xenotransplantation in the UK G Haddow, A Bruce, J Calvert, SHE Harmon, W Marsden New Genetics and Society 29 (1), 3-17, 2010 | 32 | 2010 |
Embodiment and everyday cyborgs: Technologies that alter subjectivity G Haddow Manchester University Press, 2021 | 27 | 2021 |
Governing risk, engaging publics and engendering trust: New horizons for law and social science? SHE Harmon, G Laurie, G Haddow Science and Public Policy 40 (1), 25-33, 2013 | 24 | 2013 |
Implantable smart technologies (IST): Defining the ‘sting’in data and device G Haddow, SHE Harmon, L Gilman Health Care Analysis 24, 210-227, 2016 | 22 | 2016 |
Stakeholder perspectives on new ways of delivering unscheduled health care: the role of ownership and organizational identity G Haddow, CA O’Donnell, D Heaney Journal of evaluation in clinical practice 13 (2), 179-185, 2007 | 22 | 2007 |
New risks inadequately managed: the case of smart implants and medical device regulation SHE Harmon, G Haddow, L Gilman Law, innovation and technology 7 (2), 231-252, 2015 | 20 | 2015 |
Can the governance of a population genetic data bank effect recruitment? Evidence from the public consultation of Generation Scotland G Haddow, S Cunningham-Burley, L Murray Public Understanding of Science 20 (1), 117-129, 2011 | 19 | 2011 |
Generation Scotland preliminary consultation exercise 2003-04: Public and stakeholder views from focus groups and interviews G Haddow, S Cunningham-Burley, A Bruce, S Parry Edinburgh: ESRC INNOGEN Centre, University of Edinburgh, 2004 | 19 | 2004 |
“We only did it because he asked us”: gendered accounts of participation in a population genetic data collection G Haddow Social Science & Medicine 69 (7), 1010-1017, 2009 | 18 | 2009 |
Implementation of a national, nurse-led telephone health service in Scotland: assessing the consequences for remote and rural localities A Roberts, D Heaney, G Haddow, CA O'Donnell Rural and remote health 9 (2), 1-9, 2009 | 18 | 2009 |